about
Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 ComparisonBrugada syndrome risk loci seem protective against atrial fibrillation.Complex genetic background in a large family with Brugada syndrome.Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathiesDysfunction of the Voltage-Gated K+ Channel β2 Subunit in a Familial Case of Brugada Syndrome.SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patientsRegulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.The potential of endurance exercise-derived exosomes to treat metabolic diseases.Pathogenesis and management of Brugada syndrome.Sudden arrhythmic death: from basic science to clinical practiceRepeated molecular genetic analysis in Brugada syndrome revealed a novel disease-associated large deletion in the SCN5A gene.Denervation-related alterations and biological activity of miRNAs contained in exosomes released by skeletal muscle fibers.Genomic-based diagnosis of arrhythmia disease in a personalized medicine era.Regulation of Cardiac Voltage-Gated Sodium Channel by Kinases: Roles of Protein Kinases A and C.Postmortem genetic analysis of sudden unexpected death in infancy: neonatal genetic screening may enable the prevention of sudden infant death.Next generation sequencing applications for cardiovascular disease.Brugada Syndrome-Associated Genetic Loci Are Associated With J-Point Elevation and an Increased Risk of Cardiac ArrestMutations in voltage-gated L-type calcium channel: implications in cardiac arrhythmia
P2860
Q26772794-D72EEDA0-28B5-49AD-9E01-E1A669623BBEQ34508291-1264DB81-B4BB-4F5A-8860-6C2E8D791652Q35294252-56027249-9186-4C12-BCD4-181E186E1386Q35691043-771CA38B-3283-45D7-BC99-8244B8722B3DQ36585034-23753099-6664-46E9-A7C6-DBB18FFF2411Q37076110-AAAEB2BA-0A38-46B2-9D6F-D22AF106D319Q37734653-75CF2527-636E-457A-9624-F4EC3DF9BA2AQ38752869-6C679E3F-4E4B-42DB-B959-22F9D99746ECQ38845636-EB985E2D-7498-45FA-99B8-68CC085E0C74Q38954679-D365B408-B5F4-4034-80B1-B479D03C1204Q41827537-C2D36FA9-E918-4AD8-96F4-80E0328697B6Q41903329-D8C985B7-4BE7-4709-9583-2F3A1FCD95E3Q42378932-D3F24F76-7ADD-49F0-969F-687786F9EB5CQ46129436-915436DD-BD60-4929-8AA1-339DB6941DEBQ47651784-6C0F6EB5-3DE2-4B83-BAA6-5A6332B98D87Q47765779-F2FE5FB0-4664-4E6F-80F7-0BD5EE42DD64Q47805269-3A36F4EC-5942-4E50-B845-C1B240348D38Q58061653-7AAB52E2-AA95-4F42-AD4A-C205A5AAEAB2Q58777181-7B44DE55-7DA5-4513-8CC0-3E00EC8B53CC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The genetic component of Brugada syndrome
@en
The genetic component of Brugada syndrome.
@nl
type
label
The genetic component of Brugada syndrome
@en
The genetic component of Brugada syndrome.
@nl
prefLabel
The genetic component of Brugada syndrome
@en
The genetic component of Brugada syndrome.
@nl
P2093
P2860
P356
P1476
The genetic component of Brugada syndrome
@en
P2093
Morten S Olesen
Morten W Nielsen
Søren-Peter Olesen
P2860
P356
10.3389/FPHYS.2013.00179
P577
2013-07-15T00:00:00Z